Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRPS18CP4 is a copied, non-functional sequence derived from the Mitochondrial Ribosomal Protein S18C gene. Mitochondrial ribosomal protein pseudogenes arose through processes such as retrotransposition or gene duplication, resulting in sequences that typically lack coding potential and may show significant divergence from the original gene[3]. Pseudogenes serve as evolutionary records but do not generally encode active proteins or participate in cellular functions. There is no evidence of MRPS18CP4 encoding a protein or being a drug target, and its biological or disease role is presumed negligible.
None — No drugs act via MRPS18CP4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRPS18C pseudogene 4 (MRPS18CP4).